Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial (Q30521133)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial
scientific article

    Statements

    Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial (English)
    Nicholas D James
    Malcolm D Mason
    John Anderson
    David P Dearnaley
    John Dwyer
    Gordana Jovic
    Alastair W S Ritchie
    J Martin Russell
    Karen Sanders
    George N Thalmann
    Gianfilippo Bertelli
    Alison J Birtle
    Joe M O'Sullivan
    Andrew Protheroe
    Denise Sheehan
    Narayanan Srihari
    Mahesh K B Parmar
    STAMPEDE investigators
    26 March 2012
    549-558

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit